Press Releases

PORTLAND, Ore., Nov. 11, 2019 /PRNewswire/ -- Mercy, which serves patients across four states, will deploy Bright.md's asynchronous virtual care product to deliver the industry's premier patient-focused online care experience and improve patient convenience and access. Already a leader in virtual care delivery, Mercy will integrate Bright.md services into their care

SPRING HOUSE, Pa., Nov. 11, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced 24-week Phase 3 data showing a significantly greater proportion of patients with active psoriatic arthritis (PsA) treated with TREMFYA® (guselkumab) achieved at least a 20 percent improvement in disease signs and sympto

LEXINGTON, Mass., Nov. 11, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that it received $10M upfront for a License Agreement with UroGen Pharma Ltd. Un

BOSTON, Nov. 11, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will report third quarter 2019 financial results on Thursday, November

MONTREAL, Oct. 31, 2019 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2020 second quarter results on Wednesday, November 13, 2019. A conference call will be held on the same day at 1 p.m. Eastern Time (ET) to provide analysts and institutional investors with a review of CAE's per

NESS ZIONA, Israel, Nov. 11, 2019 /PRNewswire/ -- Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, today announced that it will present the interim results of Cohort A of its ongoing Phase 1/2a Clinical Trial in ALS (as published in

Dr. Kerklaan Therapeutics amongst the first CBD products to be on shelves at Selfridges, DFS North America, Dillard's and Lord + Taylor LOS ANGELES, Nov. 8, 2019 /PRNewswire/ -- Dr. Kerklaan Therapeutics (

SUZHOU, China, Nov. 11, 2019 /PRNewswire/ -- TenNor Therapeutics reported positive top-line results for TNP-2092 powder for injection from a phase II clinical trial conducted in the United States. TNP-2092 is currently under clinical development for the treatment of prosthetic joint

ATLANTA, Nov. 11, 2019 /PRNewswire/ -- At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery (HSS) presented their method for developing and implementing effective educational programs for diverse patients w

VIMOVO Litigation to Continue MISSISSAUGA, ON, Nov. 11, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that the United States District Court